Anbio Biotechnology (NNNN) Assets (2023 - 2025)

Anbio Biotechnology has reported Assets over the past 3 years, most recently at $30.2 million for Q4 2025.

  • Quarterly results put Assets at $30.2 million for Q4 2025, up 59.83% from a year ago — trailing twelve months through Dec 2025 was $30.2 million (up 59.83% YoY), and the annual figure for FY2025 was $30.2 million, up 59.83%.
  • Assets for Q4 2025 was $30.2 million at Anbio Biotechnology, up from $18.9 million in the prior quarter.
  • Over the last five years, Assets for NNNN hit a ceiling of $30.2 million in Q4 2025 and a floor of $15.8 million in Q4 2023.
  • Median Assets over the past 3 years was $18.9 million (2024), compared with a mean of $21.7 million.
  • Biggest five-year swings in Assets: increased 19.67% in 2024 and later surged 59.83% in 2025.
  • Anbio Biotechnology's Assets stood at $15.8 million in 2023, then rose by 19.67% to $18.9 million in 2024, then surged by 59.83% to $30.2 million in 2025.
  • The last three reported values for Assets were $30.2 million (Q4 2025), $18.9 million (Q4 2024), and $15.8 million (Q4 2023) per Business Quant data.